# Avego Bioscience Capital: portfolio, investments and team > Avego Bioscience Capital is a private equity. 8 investments on record, 4 in the last 12 months, latest Jun 2026. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/avego-bioscience-capital (Millionrounds; every figure on the page links to its filing or article) [Investor](https://millionrounds.com/investors) # Avego Bioscience Capital Last cheque observed Jun 2026; 8 cheques on record. Email Deploying now New fund $60M, Apr 2026 Private equity Series A Series B Series D Follow Avego Bioscience Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Favego-bioscience-capital) Deploying now **80%** of best year **4** **cheques in 12 months**, 8 on record Since the last cheque **152** days **00** hrs **00** min **00** sec Median round **$140M** Rounds led **1 of 8** Mostly in **United States, 63%** Pitch Avego Bioscience Capital ## Avego Bioscience Capital highlights - 01 4 cheques in the last 12 months - 02 Mostly Series A and Series B: 63% of its rounds - 03 Led 1 rounds ## What they do - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **8 appearances** - **2026** 4 rounds - **Jun** **[Memento Medicines](https://millionrounds.com/company/memento-medicines)** Series A · GB · Avego Management **$93M** *Led* - **Feb** **[Alveus Therapeutics Inc.](https://millionrounds.com/company/alveus-therapeutics-inc)** Series A · US · Seroba Life Sciences **$197M** With 8 others - **Jan** **[Alveus Therapeutics](https://millionrounds.com/company/alveus-therapeutics)** Series A · US · Avego Management **$160M** With 5 others - **Jan** **[EpiBiologics](https://millionrounds.com/company/epibiologics)** Series B · US · Avego Management **$107M** With 11 others - **2025** 2 rounds - **Jul** **[MapLight Therapeutics](https://millionrounds.com/company/maplight-therapeutics)** Series D · US · Avego Management **$373M** With 8 others - **May** **[CellCentric](https://millionrounds.com/company/cellcentric)** Series C · GB · Avego Management **$120M** With 3 others - **2024** 2 rounds - **Nov** **[Alentis Therapeutics](https://millionrounds.com/company/alentis-therapeutics)** Series D · CH · Avego Management **$181M** With 11 others - **Nov** **[TRex Bio](https://millionrounds.com/company/trex-bio)** Series B · US · Avego Management **$84M** With 8 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **2 named** AR **Alyssa Romano** Chief Compliance Officer of the General Partner i Filing they signed BV **Balaji Venkataraman** Managing Member of the General Partner i Filing they signed We also hold **2** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. New fund on file **$60M** raised in Apr 2026 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Series A Series B Series D Median round joined **$140M** the round, not its cheque Led 1 of 8 rounds **13%** - **Sole investor:** Never alone - **Last cheque:** Jun 2026 Rounds by stage said on their site - Series A *3* - Series B *2* - Series D *2* - Series C *1* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Sanofi](https://millionrounds.com/fund/sanofi) 4 - [Forbion Capital Partners](https://millionrounds.com/fund/forbion-capital-partners) 3 - [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 3 - [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) 3 - [Andera Partners](https://millionrounds.com/fund/andera-partners) 2 - [Jeito Capital](https://millionrounds.com/fund/jeito-capital) 2 **Pitching Avego Bioscience Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Avego Bioscience Capital. A count of rooms they were both in, not a relationship either has claimed. [**Sanofi** Investment firm **4** rounds together](https://millionrounds.com/fund/sanofi)[**Forbion Capital Partners** Private equity **3** rounds together](https://millionrounds.com/fund/forbion-capital-partners)[**Novo Holdings** VC firm **3** rounds together](https://millionrounds.com/fund/novo-ventures)[**RA Capital Management** Private equity **3** rounds together](https://millionrounds.com/fund/ra-capital-management)[**Andera Partners** Private equity **2** rounds together](https://millionrounds.com/fund/andera-partners)[**Jeito Capital** VC firm **2** rounds together](https://millionrounds.com/fund/jeito-capital)[**KurmaPartners** VC firm **2** rounds together](https://millionrounds.com/fund/kurmapartners)[**New Rhein** Private equity **2** rounds together](https://millionrounds.com/fund/new-rhein-healthcare-investors)[**Omega Funds** VC firm **2** rounds together](https://millionrounds.com/fund/omega-funds)[**Polaris Partners** VC firm **2** rounds together](https://millionrounds.com/fund/polaris-partners)[**Samsara BioCapital** VC firm **2** rounds together](https://millionrounds.com/fund/samsara-biocapital) ## Recently backed The latest companies Avego Bioscience Capital put money into. [**Alveus Therapeutics Inc.** $197M · Feb 2026](https://millionrounds.com/company/alveus-therapeutics-inc)[**EpiBiologics** $107M · Jan 2026](https://millionrounds.com/company/epibiologics)[**MapLight Therapeutics** $373M · Jul 2025](https://millionrounds.com/company/maplight-therapeutics)[**CellCentric** $120M · May 2025](https://millionrounds.com/company/cellcentric)[**Alentis Therapeutics** $181M · Nov 2024](https://millionrounds.com/company/alentis-therapeutics) ## Quick answers about Avego Bioscience Capital ### What does Avego Bioscience Capital invest in? Avego Bioscience Capital invests most often at Series A and Series B (63% of the rounds on record). ### How active is Avego Bioscience Capital? 8 investments on record, 4 of them in the last 12 months, and it led 1. The most recent was in Jun 2026. ### What has Avego Bioscience Capital invested in recently? Its most recent investments on record: Memento Medicines (Series A, Jun 2026), Alveus Therapeutics Inc. (Series A, Feb 2026) and Alveus Therapeutics (Series A, Jan 2026). ### How big are Avego Bioscience Capital's cheques? The median round it joins is $140M. ### Does Avego Bioscience Capital lead rounds? Sometimes: it led 1 of its 8 investments on record (13%). ### Where does Avego Bioscience Capital invest? Most of the companies it backs are in the United States (63%), the United Kingdom (25%) and Switzerland (13%). ### Is Avego Bioscience Capital investing now? Yes: it is actively investing, with 4 investments in the last 12 months. ### Who does Avego Bioscience Capital invest alongside? Most often Sanofi (4 rounds together), Forbion Capital Partners (3 rounds together) and Novo Holdings (3 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=avego-bioscience-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=avego-bioscience-capital)